Ratte, A., Wiedmann, F. T., Kraft, M., Katus, H., & Schmidt, C. (2019). Antiarrhythmic properties of ranolazine: Inhibition of atrial fibrillation associated TASK-1 potassium channels. Frontiers in pharmacology, 10, . https://doi.org/10.3389/fphar.2019.01367
Chicago Style (17th ed.) CitationRatte, Antonius, Felix Tobias Wiedmann, Manuel Kraft, Hugo Katus, and Constanze Schmidt. "Antiarrhythmic Properties of Ranolazine: Inhibition of Atrial Fibrillation Associated TASK-1 Potassium Channels." Frontiers in Pharmacology 10 (2019). https://doi.org/10.3389/fphar.2019.01367.
MLA (9th ed.) CitationRatte, Antonius, et al. "Antiarrhythmic Properties of Ranolazine: Inhibition of Atrial Fibrillation Associated TASK-1 Potassium Channels." Frontiers in Pharmacology, vol. 10, 2019, https://doi.org/10.3389/fphar.2019.01367.